-
Big Data = Better Global Health?: What impact will the Global Burden of Disease study have?
The Global Burden of Disease (GBD) Study is the most ambitious effort to date to quantify the world’s health status. Involving 486 collaborators from 302 institutions in 50 countries, the study has been compared to the Human Genome Project in terms of potential impact. But health experts have criticized it as nontransparent and lacking accountability. What role will the GBD Study play in global health policymaking - and how can it be improved?
- Categories
- Education, Health Care
- Tags
- public health, research
-
D-Rev’s “Brilliance” Goes Global: CEO Krista Donaldson on designing products for the poor – and how to get businesses to sell them
Last week D-Rev announced that its Brilliance medical device for treating newborns with severe jaundice is now available for the global market. In this interview, D-Rev CEO Krista Donaldson explains how the non-profit makes a business case to manufacturers and distributors.
- Categories
- Health Care
-
What’s Next for Impact Investing – Facing Market Realities: Why the environment is the core of impact investing in China
When I first started China Impact Fund, I thought that impact investing in China should give equal weight to the country’s social and environmental issues, just as what my peers do in most other emerging markets. As I am relocating back to China, my thinking evolved toward environmental for several key reasons.
- Categories
- Environment, Investing
- Tags
- impact investing
